
Stable Is Not the Same as Fine
We live scan to scan. If you’ve walked this road, you know exactly what that means.
Brainstorm Health is where lived experience meets understanding. We explore the real questions, patterns, and moments that emerge for patients and caregivers navigating serious illness—and what they reveal about how support can be better designed.
Live Last read · last published · next check

We live scan to scan. If you’ve walked this road, you know exactly what that means.

There is a loss that almost never gets talked about in glioblastoma.

Glioblastoma does not arrive into perfect relationships.

Every few weeks there’s another headline announcing a potential breakthrough for glioblastoma.

In glioblastoma, treatment decisions are often described as if they happen in a clean sequence.

There is a moment in serious illness that can fool almost anyone.

A Phase I glioblastoma trial can look complete on paper.

GBM drug development is hard because the biology is hard.

Before there were conversations about grief, there were marriages.

GBM care depends on people the system does not fully count.

The official GBM journey has a shape.

Every July, Glioblastoma Awareness Day asks people to look toward a disease most families never expect to learn about.

When Jason recently asked me if I wanted to write an article for Brainstorm Health, I immediately said yes.

I can’t believe I started a company at nearly 50.

Today, my wife completed her second week of healing (radiation) sessions, so one third of her radiation treatments down.

A recent article from Parexel on the evolving EU Health Technology Assessment (HTA) framework caught my attention.

I recently read Evinova and ISPEP’s new report introducing the EACH Framework for patient-focused clinical trial recruitment.

Bristol Myers Squibb recently published a white paper on early patient engagement in drug development. At its core is a simple but important idea: patients, caregivers, and advocacy organizations should be involved before key decisions are made, not after. The paper argues that lived experience should help shape development strategy, trial design, recruitment approaches, communications, and…

The weight of caregiving isn’t invisible because it’s small. It’s invisible because it’s everywhere.

After a weekend at ASCO, I finally had a chance to come home.